SUVEN PHARMACEUTICALS
Back to Balance Sheet
|
SUVEN PHARMACEUTICALS Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹488 Cr | ₹1,136 Cr | ₹852 Cr | ₹918 Cr | ₹345 Cr |
What is the latest Net Current Assets ratio of SUVEN PHARMACEUTICALS ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹488 Cr |
| Mar2024 | ₹1,136 Cr |
| Mar2023 | ₹852 Cr |
| Mar2022 | ₹918 Cr |
| Mar2021 | ₹345 Cr |
How is Net Current Assets of SUVEN PHARMACEUTICALS Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹488 Cr | -57.03 | |
| Mar2024 | ₹1,136 Cr | 33.27 | |
| Mar2023 | ₹852 Cr | -7.12 | |
| Mar2022 | ₹918 Cr | 165.95 | |
| Mar2021 | ₹345 Cr | - | |
Compare Net Current Assets of peers of SUVEN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUVEN PHARMACEUTICALS | ₹11,789.8 Cr | -1.7% | -18.8% | -73.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹428,185.0 Cr | 3% | 9.5% | 3.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,766.0 Cr | 1.7% | 3.1% | 5.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,923.0 Cr | 4.7% | 11.7% | 41.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,081.0 Cr | 2.1% | 6.7% | 11.6% | Stock Analytics | |
| CIPLA | ₹109,680.0 Cr | 1.3% | 1.3% | -9.4% | Stock Analytics | |
SUVEN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUVEN PHARMACEUTICALS | -1.7% |
-18.8% |
-73.4% |
| SENSEX | -0.3% |
-0.1% |
8.3% |
You may also like the below Video Courses